Capricor Therapeutics, Inc. (CAPR)
6.81
+0.52
(+8.27%)
USD |
NASDAQ |
Aug 24, 16:00
6.80
-0.01
(-0.15%)
After-Hours: 20:00
Capricor Therapeutics Debt to Equity Ratio : 0.3698 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3698 |
| March 31, 2026 | 0.0758 |
| December 31, 2025 | 0.0587 |
| September 30, 2025 | 0.2137 |
| June 30, 2025 | 0.0421 |
| March 31, 2025 | 0.0362 |
| December 31, 2024 | 0.0332 |
| September 30, 2024 | 0.0736 |
| June 30, 2024 | 0.4532 |
| March 31, 2024 | 0.2928 |
| December 31, 2023 | 0.2483 |
| September 30, 2023 | -3.238 |
| June 30, 2023 | 2.051 |
| March 31, 2023 | 0.9297 |
| December 31, 2022 | 0.5037 |
| September 30, 2022 | 0.3991 |
| June 30, 2022 | 0.3265 |
| March 31, 2022 | 0.2508 |
| December 31, 2021 | 0.1991 |
| September 30, 2021 | 0.0919 |
| June 30, 2021 | 0.1011 |
| March 31, 2021 | 0.1015 |
| December 31, 2020 | 0.131 |
| September 30, 2020 | 0.1215 |
| June 30, 2020 | 0.1167 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.352 |
| December 31, 2019 | 0.4937 |
| September 30, 2019 | 0.9456 |
| June 30, 2019 | 1.428 |
| March 31, 2019 | 0.9027 |
| December 31, 2018 | 0.7315 |
| September 30, 2018 | 0.4837 |
| June 30, 2018 | 0.3506 |
| March 31, 2018 | 0.3205 |
| December 31, 2017 | 0.3007 |
| September 30, 2017 | -4.105 |
| June 30, 2017 | -2.620 |
| March 31, 2017 | -2.365 |
| December 31, 2016 | -4.248 |
| September 30, 2016 | 346.35 |
| June 30, 2016 | -2.376 |
| March 31, 2016 | -9.378 |
| December 31, 2015 | -8.874 |
| September 30, 2015 | 4.755 |
| June 30, 2015 | 2.01 |
| March 31, 2015 | 1.25 |
| December 31, 2014 | -1.465 |
| September 30, 2014 | -2.047 |
| June 30, 2014 | -2.802 |
| March 31, 2014 | -2.387 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| REGENXBIO, Inc. | 3.49 |
| Cytokinetics, Inc. | -7.324 |
| Emergent BioSolutions, Inc. | 1.723 |
| Rigel Pharmaceuticals, Inc. | 0.0939 |
| Ironwood Pharmaceuticals, Inc. | -2.452 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 368.74M |
| Total Liabilities (Quarterly) | 122.52M |
| Shareholders Equity (Quarterly) | 246.22M |
| Current Ratio | 7.346 |
| Net Debt Paydown Yield | -1.24% |